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Quantitative Proteomic Approach Identifies
Vpr Binding Protein as Novel Host Factor
Supporting Influenza A Virus Infections in
Human Cells*□S
Anne Sadewasser‡a, Katharina Paki‡b, Katrin Eichelbaum§c, Boris Bogdanow§d,
Sandra Saenger‡e, Matthias Budt‡f, Markus Lesch¶g, Klaus-Peter Hinzh,
Andreas Herrmann**i, Thomas F. Meyer¶j, Alexander Karlas¶k, Matthias Selbach§l,
and Thorsten Wolff‡‡‡
Influenza A virus (IAV) infections are a major cause for
respiratory disease in humans, which affects all age
groups and contributes substantially to global morbidity
and mortality. IAV have a large natural host reservoir in
avian species. However, many avian IAV strains lack ad-
aptation to other hosts and hardly propagate in humans.
While seasonal or pandemic IAV strains replicate effi-
ciently in permissive human cells, many avian IAV cause
abortive nonproductive infections in these hosts despite
successful cell entry. However, the precise reasons for
these differential outcomes are poorly defined. We hy-
pothesized that the distinct course of an IAV infection with
a given virus strain is determined by the differential inter-
play between specific host and viral factors. By using
Spike-in SILAC mass spectrometry-based quantitative
proteomics we characterized sets of cellular factors whose
abundance is specifically up- or downregulated in the
course of permissive versus nonpermissive IAV infection,
respectively. This approach allowed for the definition and
quantitative comparison of about 3500 proteins in human
lung epithelial cells in response to seasonal or low-patho-
genic avian H3N2 IAV. Many identified proteins were simi-
larly regulated by both virus strains, but also 16 candidates
with distinct changes in permissive versus nonpermissive
infection were found. RNAi-mediated knockdown of these
differentially regulated host factors identified Vpr binding
protein (VprBP) as proviral host factor because its down-
regulation inhibited efficient propagation of seasonal IAV
whereas overexpression increased viral replication of both
seasonal and avian IAV. These results not only show that
there are similar differences in the overall changes during
permissive and nonpermissive influenza virus infections,
but also provide a basis to evaluate VprBP as novel anti-IAV
drug target. Molecular & Cellular Proteomics 16: 10.1074/
mcp.M116.065904, 728–742, 2017.
Influenza viruses are a major cause for waves of respiratory
disease, which affects all age groups and can occur repeat-
edly in any particular individual. These infections have a
strong socio-economic impact as they are responsible for
about 3 to 5 million cases of severe illness annually and about
250,000 to 500,000 deaths, worldwide (1). Furthermore, influ-
enza pandemics that are caused by novel virus strains origi-
nating from animal host reservoirs of influenza A virus (IAV)1
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as well as the ongoing highly lethal zoonotic infections with
avian H5N1 and H7N9 subtype strains remain a constant
threat for the human population (2). Human influenza virus
was first isolated more than 80 years ago (3). Therefore, we
have a fairly good understanding of its structures, genetics
and principal modes of replication. In contrast, influenza virus
host interactions have only partially been explored mainly
because many analyses examined isolated properties such as
activation of a single signaling pathway or the contribution of
one gene product to virus replication (4–8). Despite the ac-
cumulated knowledge, we have also only incomplete under-
standing of the cellular factors that determine species spec-
ificity or the molecular basis for high virulence of certain
zoonotic strains. Still, knowledge of these topics is crucial for
an improved risk assessment of seasonal and emerging influ-
enza virus strains.
Viral infection leads to perturbations of many cellular func-
tions such as metabolism or DNA/protein synthesis and often
triggers an inflammatory/immune response (9). One major
question that arises from the increased detection of zoonotic
inter-species transmissions in recent years (10) concerns the
cellular factors that determine the success of a viral infection
in a given host cell in terms of generating high levels of
progeny viruses. A permissive host cell supports virus repli-
cation, gives rise to high levels of progeny viruses and will
eventually enter a lytic phase resulting in the host cell’s death.
If the host cell is nonpermissive, the virus may be internalized,
but will not efficiently produce viruses (11, 12). Only a few
early studies have addressed differences and similarities be-
tween permissive and nonpermissive IAV infections by bio-
chemical and cell biological approaches (11, 13), but system-
atic investigations of this topic are lacking. Previous holistic
analyses of IAV focused on the cellular responses to seasonal,
pandemic or mouse-adapted influenza strains at early or late
time-points of infection (14–20), or identified host factors
required for efficient IAV replication by genome-wide RNAi
screens (21–24). Simon and colleagues, for example, de-
tected more profound changes in the global proteome of the
human lung epithelial cell line A549 due to novel H7N9 and
highly pathogenic H5N1 infection compared with infection
with low-pathogenic H1N1 virus at early time points post
infection (14). Permissive influenza virus infection depends on
the virus’ ability to suppress the anti-viral host cell response,
as well as on adaptations within the viral genome that deter-
mine efficient viral entry or polymerase activity. However,
protein signatures within the host cell proteome typical for
permissive or nonpermissive course of IAV infection were not
identified, so far.
Based on metabolic SILAC labeling, we quantitatively com-
pared the proteome signatures in human lung epithelial cells
during the entire course of infection with either highly produc-
tive seasonal IAV of the H3N2 subtype or an avian H3N2 strain
causing abortive infection. The majority of the 3500 quantified
proteins per sample were similarly regulated by both virus
strains, but also candidates with distinct changes in permis-
sive versus nonpermissive infection were found. One example
was the Vpr binding protein (VprBP), also known as DCAF-1,
which was significantly downregulated selectively during non-
permissive infection. Functional validation by RNAi-mediated
knockdown identified VprBP as a novel host factor of influ-
enza virus propagation. Downregulation of VprBP inhibited
efficient propagation of seasonal IAV and reduced cellular as
well as viral gene expression. In contrast, overexpression of
VprBP increased viral protein expression and replication of
both, seasonal and avian IAV. Thus, our comprehensive pro-
teomic screen elucidated for the first time both, similarities
and differences in the host cell response to permissive and
nonpermissive infection over time and identified VprBP as a
promising host cell factor that might be suitable as a novel
anti-IAV drug target.
EXPERIMENTAL PROCEDURES
Cells and Viruses—HEK 293T and A549 cells were grown in Dul-
becco modified Eagle medium (DMEM) supplemented with 10% (v/v)
FCS, 2 mM L-glutamine, and antibiotics. MDCK type II cells were
grown in minimal essential medium (MEM) supplemented with the
same additives. Vero cells were cultivated in serum free OPTI PROTM
medium supplemented with 1.6 mM L-glutamine. All cells were main-
tained at 37 °C and 5% CO2. Stocks of the influenza viruses A/
Mallard/439/2004 (H3N2) (Mal) (GISAID accession numbers EPI859640-
EPI859647) and A/Turkey/Italy/472/1999 (H7N1) (Turk/It) were grown
in the allantoic cavities of 10-day-old embryonated chicken eggs for
3 days at 37 °C. Virus stocks of A/Panama/2007/1999 (H3N2) (Pan)
(NCBI accession numbers: DQ487333-DQ487340) and A/Udorn/307/
1972 (H3N2) (Udorn) (NCBI accession numbers: DQ508926-DQ508933)
were propagated in MDCK type II cells for 2 days at 37 °C. Pan NS1
virus was grown in Vero cells for 2 days at 37 °C. To analyze viral
replication, confluent A549 or Vero cell cultures were infected at an
MOI of 0.01 and incubated for 48 or 72 h at 37 °C in culture medium
containing 0.2% (w/v) BSA and trypsin. Virus titers were determined
on MDCK type II cells by standard plaque assay (25).
Plasmids and Antibodies—FLAG-tagged construct DCAF1-iso1
(Gen-Bank accession number NP_055518) was kindly provided by
Florence Margottin-Goguet (26). The following antibodies were used
in this study: anti-CrkL (Merck Millipore), anti-VprBP (Abcam), anti-
Rsl1D1 (Sigma-Aldrich), anti-SAMHD1 (Sigma-Aldrich), anti-NP (Se-
rotec), anti-M1 (Serotec), anti-NS1 (27), anti-HA (abcam), anti-PA
(GeneTex), anti-Actin (Sigma-Aldrich).
Spike in SILAC (Stable Isotope Labeling by Amino Acids in Cell
Culture)-based mass spectrometry to measure host proteome re-
sponse to IAV infection—A549 cells were grown in stable isotope-








15N2) arginine and lysine (Cambridge Isotope Laboratories,
Tewksbury, MA), 10% dialyzed FBS (Invitrogen), 2 mM L-glutamine
and antibiotics for at least six cell doublings prior to infection. Suc-
cessful incorporation of heavy amino acids was verified by MS with
incorporation rates of 98.7% for lysine and 97.1% for arginine. Heavy-
labeled cells were mock infected to generate heavy labeled reference
proteins, while light-labeled cells were infected with Pan or Mal virus
at an MOI of 3. At indicated time points cell extracts were prepared
using 1% SDS lysis buffer (20 mM Tris-HCl [pH7.5], 150 mM NaCl, 1%
SDS). Protein concentration of each lysate was determined by BCA
protein assay (Thermo Fisher Scientific), and each light cell lysate was
spiked at a 1:1 ratio with heavy-labeled reference proteins.
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Experimental Design and Statistical Rationale—Each sample for
mass spectrometry (MS) analysis was generated by combining two
individual SILAC-labeled cell populations. In total 20 samples, two
biological replicates for each time point post infection (p.i.) (0 h, 4 h,
8 h, 16 h, 24 h) with Pan or Mal virus were analyzed (Fig. 2). R0K0-
labeled, mock-infected A549 cells served as internal standard control.
The different time points p.i. were chosen to cover the entire course
of infection. Scatter plot analyses and calculation of Pearson corre-
lation were performed to ensure reproducibility of biological repli-
cates. Statistical tests were performed by volcano plot analysis (t test,
both sides, FDR 0.05) using Perseus (V. 1.5.0.31).
Sample Preparation—After lysis samples were reduced by adding
DTT to a final concentration of 0.1 M and incubation for 5 min at 95 °C.
Sulfhydryl groups were alkylated by adding iodoacetamide to a final
concentration of 0.25 M and incubation for 20 min in the dark at room
temperature. Proteins were precipitated according to Wessel and
Fluegge (28), resuspended in 6 M urea/2 M thiourea and digested into
peptides with C-terminal lysine or arginine using Lys-C (3 h) and
Trypsin (overnight, diluted 4 with 50 mM ABC). Enzyme activity was
quenched by acidification of the samples with trifluoroacetic acid. The
peptides were desalted with C18 Stage Tips (29) prior to nanoLC-
MS/MS analysis.
LC-MS/MS Analysis—Peptides were separated on a 2-m mono-
lithic column (MonoCap C18 High Resolution 2000 (GL Sciences
Einhoven, The Netherlands), 100 m i.d.  2000 mm at a flow rate of
300 nL/min with a 5 to 45% acetonitrile gradient on an EASY-nLC II
system (Thermo Fisher Scientific) with 480 min gradient. A Q Exactive
plus instrument (Thermo Fisher Scientific) was operated in the data
dependent mode with a full scan in the Orbitrap followed by top 10
MS/MS scans using higher-energy collision dissociation (HCD). The
full scans were performed with a resolution of 70,000, a target value
of 3  106 ions and a maximum injection time of 20 ms. The MS/MS
scans were performed with a 17,500 resolution, a 1 106 target value
and a 60 ms maximum injection time.
Peptide and Protein Identification—Peak lists were generated from
raw data files using MaxQuant software version 1.5.1.2 according to
the standard workflow (30), which corrects for systematic inaccura-
cies of measured peptide masses and corresponding retention times
of extracted peptides (30, 31). Proteins were identified by searching
against the recent Uniprot human database (2013–4; 89,601 protein
sequences) as well as 12 viral protein sequences of Pan and Mal
virus. Proteins were identified using the integrated Andromeda search
engine and the following search parameters: carbamidomethylation
of cysteine as a fixed modification, oxidation of methionine, acetyla-
tion of protein N terminus, deamidation of asparagine and glutamine
(32) and appropriate SILAC labels as variable modifications; tryptic
digestion with a maximum of two missed cleavages; a peptide pre-
cursor mass tolerance of 20 ppm and a fragment mass tolerance of
4.5 ppm. Known contaminants were included for protein identification
(2014–11; contaminant.fasta, MaxQuant). Intensity threshold was set
to 500 (default setting). The decoy database search option was en-
abled and all peptide spectrum matches (PSMs) and proteins were
filtered with a maximum false discovery rate (FDR) of 0.01 by using
the MaxQuant target-decoy approach. Annotated spectra can be
visualized using the ProteinProspector MS-viewer (33) with the fol-
lowing search key: jt7cvdk2q3. The mass spectrometry proteomics
data have been deposited to the ProteomeXchange Consortium
(http://proteomecentral.proteomexchange.org) via the PRIDE partner
repository with the data set identifier PXD005825.
Protein Quantification—The MaxQuant output file proteinGroups.
txt was used to determine relative protein abundance by means of
Perseus software version 1.5.0.31. This table contains information on
the identified proteins, sequence coverage, number of unique pep-
tides and their H/L ratios in the processed raw-files. Each single row
contains the group of proteins that could be reconstructed from a set
of peptides. Protein quantification was performed with at least 2
unique and razor (i.e. peptides shared by different proteins of a group)
peptides by means of the measured peak intensities. The relative
abundance of a protein was derived from its H/L ratio in the differently
labeled cell populations. An H/L ratio of 0.5 for a given protein was
considered to signal increased abundance in the infected R0K0 cell
population. Scatter plot analyses and calculation of Pearson correla-
tion were performed to ensure reproducibility of biological replicates.
Thereby, PWP1 protein was excluded as outlier in the Pan_4h data
set, because of strong variation between the two replicates (Rep1:
80.50; Rep2: 0.15). Because data sets have normal distribution,
significant differences between data points were determined by t test
using volcano plot analysis. A p value  0.05 was considered signif-
icant. Principle component analysis (PCA) (cutoff method: Benjamini-
Hochberg; FDR 0.05) and IDAS 2.1 (34) hierarchical clustering (Eu-
clidian distance) were used to display structure and variance of
significant proteins having valid values in each sample. Classification
of proteins with significant log2(fold change)1 or-1 upon infection
with Pan or Mal virus was performed using PANTHER (Protein anal-
ysis through evolutionary relationships) Classification System Version
10.0 according to their gene ontology terms “biological process”
(GOBP).
Immunofluorescence Microscopy—IAV infected A549 cells (MOI 1
and 0.5, respectively, as indicated) were used for indirect immuno-
fluorescence staining (35). Viral NP and cellular SAMHD1 proteins
were detected with primary antibodies as well as suitable secondary
anti-mouse IgG conjugated with Alexa Fluor-594 dye and anti-rabbit
IgG conjugated with Alexa Fluor-488 dye (Life Technologies GmbH,
Darmstadt, Germany), respectively. Images of cells were captured
using Axio Observer.D1 (Zeiss, Jena, Germany) or LSM510 Meta
confocal laser scanning microscope with a C-Apochromat 63/1.2
water objective lens (Zeiss) and a pinhole setting of 1, as indicated.
Data were analyzed and processed with the Zeiss ZEN 2012 (blue
edition) and Adobe Photoshop CS6 software packages. For quanti-
fication of SAMHD1 positive and negative cells, values below a
threshold of 52 were classified as SAMHD1 negative by means of the
“Histo” function of Zeiss ZEN 2012 software package.
Immunoblot Analysis—To analyze protein expression levels, A549
cells were mock-treated or infected with indicated viruses at an MOI
of 2 or 3, respectively. Cell extracts were prepared at indicated time
points in 1% SDS lysis buffer and subjected to SDS-PAGE and
immunoblot analysis. Proteins were detected with specific primary
and suitable secondary antibodies together with an enhanced chemi-
luminescence protocol (Thermo Fisher Scientific).
Minigenome Reporter Assay—Cellular and viral gene expression
was analyzed by a luciferase reporter minigenome assay (36). Briefly,
293T cells were transiently transfected with the pHW-Pan expression
plasmids coding for PB1, PA, PB2 (50 ng of each), and NP (100 ng) as
well as pPol-NS-Luc (50 ng) encoding a firefly luciferase cDNA (Luc)
of negative polarity flanked by the noncoding regions of the viral NS
segment. The constitutive expression vector pTK-RL (5 ng) (Promega,
Mannheim, Germany) was used to detect changes in cellular gene
expression levels by means of constitutive renilla luciferase (RL) ex-
pression. The effect of VprBP on cellular and viral gene expression
was analyzed by co-transfection of the expression construct (500 ng)
or 50 pmol Flexitube siRNA (Qiagen, Hilden, Germany), respectively.
IFN- ELISA—Cell culture supernatant samples from infected cell
cultures (MOI 2, 24 h p.i.) were stored at 80 °C, thawed at room
temperature and IFN- concentrations were measured using a human
IFN- ELISA Kit (Fujirebio Inc./Invitrogen, Karlsruhe, Germany).
SiRNA-mediated Knockdown Experiments—All siRNAs (Silencer®
Select) were purchased from Thermo Fisher. A549 cells were re-
versely transfected with siRNAs in 96-well plates at final siRNA con-
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centrations of 20 nM. For this, 8000 cells were added to the siRNAs,
which were complexed previously by adding HiPerfect (1.4 l per
well, Qiagen). The cells were incubated for an additional 48 h at 37 °C,
5% CO2. To assess the cytotoxicity of siRNAs, a WST-1 assay
(Roche) was performed 48 h post transfection by adding WST-1
reagent to the cells, followed by incubation at 37 °C for 1.5 h. Ab-
sorbance was measured at 460 nm and at the reference wavelength
590 nm. Nontargeting siRNA and siPLK1 (target sequence: CAC-
CATATGAATTGTACAGAA) were used as positive and negative con-
trol, respectively. The sequences of the siRNAs used can be obtained
upon request.
Virus replication in siRNA-transfected cells was assessed 48 h
post-transfection by washing the cells with PBS, followed by inocu-
lation with either Pan or Mal viruses at MOI 0.02. After 1 h, infection
medium (DMEM supplemented with 0.2% bovine serum albumin, 4
mM L-glutamine and antibiotics) containing 1 g/ml TPCK-treated
trypsin (Sigma-Aldrich) was added and cells kept under normal cul-
ture conditions for 39 h (Pan virus) or 48 h (Mal virus). To quantify the
virus load upon siRNA knockdown, the supernatants were harvested
and added to MDCK cells, seeded the day before at 10,000/well. To
this end, MDCK cells were washed with PBS and inoculated with
undiluted (Mal virus) or diluted (1:100, Pan virus) supernatants for 1 h.
Virus was removed and MDCK cells were cultured for 6 h with
infection medium. Cells were stained for nuclei (Hoechst, Sigma) and
the viral NP using a monoclonal NP-specific antibody, and the infec-
tion rate (i.e. the percentage of NP positive cells) was determined as
described previously (21). The final read-out of the assay was the
virus titer, which was extrapolated from the infection rate using the
following formula: multiplicity of infection  -ln(1-infection rate). Raw
data were further analyzed using the R package cellHTS2 (37). Data
normalization was performed by scaling the raw data relative to an
inactive (nontargeting) and an active (siNP, target sequence:
AAGGAUCUUAUUUCUUCGGAG) siRNA. Finally, a Z-score transfor-
mation was applied, and based on the calculated Z-scores, hits with
Z-score 1.5 or 1.5 were selected.
Statistical Analysis of Non-MS Data—Data were presented as
mean and standard deviation. Using GraphPad Prism 5 software the
Mann-Whitney U test was performed to delineate significant differ-
ences (p  0.05 (*), p  0.01 (**), p  0.001 (***)) between data points
if not indicated otherwise.
RESULTS
Replication of Low-pathogenic Avian H3N2 Influenza Virus
is Restricted in Human Lung Epithelial Cells—Despite suc-
cessful replication in birds, many avian IAV are not adapted to
propagate efficiently in humans as they lack the necessary
adaptation (38). This restriction is likely a multifactorial proc-
ess, but can even be observed in cultured human cells that
are largely nonpermissive for avian IAV (12, 39, 40). To gain
novel insights into the cellular factors determining these dif-
ferences, we chose to compare two viruses of the H3N2
subtype, seasonal A/Panama/2007/1999 (Pan) and the low-
pathogenic avian A/Mallard/439/2004 (Mal) virus. Both viruses
entered human A549 lung epithelial cells with similar effi-
ciency, as demonstrated by immunofluorescence detection of
the viral NP in infected cells (Fig. 1A). Immunoblot analysis
showed that both viruses expressed comparable levels of
viral proteins in A549 cells, although there were differences in
the relative accumulation of the M1 and NS1 gene products
(Fig. 1B). Interestingly, only the seasonal Pan virus, but not the
avian Mal virus replicated efficiently in A549 cells to final titers
of 107 PFU/ml in a multicyclic setting (Fig. 1C). In contrast,
Mal virus titers were significantly decreased by 3 log steps at
72 h p.i. demonstrating that human lung epithelial cells are
highly permissive for Pan but not for the avian Mal virus (Fig.
1C). In general, a permissive infection indicates that a virus
avoids or suppresses activation of innate cellular defenses
such as the antiviral type I interferon (IFN) system (41). To
analyze whether the avian Mal virus was unable to suppress
the innate IFN response, we determined the IFN- levels in the
supernatant of infected cells. However, Mal virus infection did
not trigger increased IFN- secretion whereas the seasonal
Pan virus provoked only modest IFN- levels most likely due
to efficient suppression of IFN expression (35) (Fig. 1D). As a
control, the recombinant influenza Pan NS1 mutant virus
was used to determine strong influenza virus-dependent
IFN- induction in the absence of antagonistic NS1 protein
(27). Growth curve analyses in Vero cells that do not express
intact IFN-/ genes showed similar differences in the repli-
cation of the Pan and Mal viruses suggesting that the poor
propagation of the avian virus in human cells is not caused by
the type I IFN response (Fig. 1E).
Human Proteome Response to Permissive versus Nonper-
missive Influenza A Virus Infection—Here, we used a global
approach to systematically analyze sets of cellular factors
whose abundance is specifically up- or downregulated during
the course of permissive versus nonpermissive IAV infection
using the two H3N2 strains. Based on metabolic SILAC label-
ing of two cell populations that enables the relative quantifi-
cation and comparison of cellular proteomes (42), we gener-
ated a mock-infected cell population labeled with heavy
arginine and lysine. Lysate of this cell population was used as
internal standard and spiked into each sample of a second
cell population being cultivated in medium with light arginine
and lysine. The cultures of light-labeled cells were infected
with seasonal or avian H3N2 viruses for 0, 4, 8, 16, or 24 h,
respectively, in two experimental repeats (Fig. 2). After the MS
measurement, SILAC-spiking enabled the direct comparison
of all samples in a quantitative manner (Fig. 2).
Data evaluation was performed with MaxQuant, which cal-
culates protein heavy to light ratios as the median of all
peptide ratios assigned to a distinct protein or protein group
(30, 31). Only unique and razor peptides were used for protein
quantification with a minimum ratio count of two and a FDR of
1%. The MS measurement resulted in identification of 4000
protein groups and quantification of about 3500 protein
groups per sample (Fig. 3A, supplemental Table S1). We did
not attempt to unambiguously identify which member of a
protein group was present; for clarity, “protein groups” will be
referred to as “proteins” hereafter. Accession numbers of all
proteins that were combined into a protein group are provided
in each of the supplementary Tables S1–S4. Peptide se-
quences used for protein identification are listed in supple-
mental Table S2, whereas supplemental Table S3 indicates
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those peptides unique for a protein group and a specific
protein, respectively. Quantification values were specified as
log2 (light to heavy ratios) (L/H) to display changes in protein
abundance upon infection. Reproducibility of both biological
replicates was verified by scatter plot analysis and calculation
of Pearson correlation (Fig. 3B, supplemental Fig. S1). De-
pending on time point and virus strain, the Pearson correlation
ranged from 0.67 to 0.76 (Mal) and 0.28 to 0.81 (Pan) (Fig. 3B,
supplemental Fig. S1). Statistically significant differences of
protein expression levels in two different samples were cal-
culated by t test using a cutoff of 1 and 1 (log2(L/H)),
respectively, and a p value  0.05, meaning that protein
abundances changed at least 2-fold upon infection (supple-
mental Table S4). Interestingly, analysis of data structure and
variance using PCA as well as IDAS 2.1 hierarchical cluster
analysis (34) revealed that the 20 generated samples assem-
bled according to the infection period rather than the used
viruses (Fig. 3C–3D), indicating that similar cellular processes
occur during both, permissive and nonpermissive, IAV infec-
tion. Fig. 3C–3D clearly shows increasing variation between
the samples during the course of viral infection.
Changes in protein abundance at early and late time points
post infection in comparison to the 0 h time point were dis-
played by volcano plot analyses (Fig. 4A–4B). Proteins with p
values  -log(0.05) are displayed in blue, while red dots
represent significantly regulated cellular proteins beyond the
cutoff of 1 and 1, respectively. These evaluations revealed
that changes in protein expression levels increase during viral
infection independent of the virus strain used (Fig. 4A–4B).
Thereby, most proteins were significantly downregulated
compared with 0 h p.i., which likely reflects the global host cell
shut off known for IAV infected cells (43). In total, we identified
135 significantly regulated proteins upon Pan or Mal infection
which were involved in comparable biological processes,
FIG. 1. Replication of low-pathogenic avian H3N2 influenza virus is restricted in human lung epithelial cells despite successful
internalization. A, A549 cells were infected with Pan or Mal virus at MOI of 1 for 4 h. Cells were fixed, permeabilized, stained with DAPI and
specific primary antibody against NP. Images were representative for five independent experiments. Scale bar: 10 m. B, A549 cells were
infected with Pan or Mal virus at an MOI of 2 for indicated time points. Cell lysates were prepared and subjected to immunoblot analyses; n 
3. C, A549 cells were infected with indicated viruses at an MOI of 0.01. Supernatants were collected at indicated time points and titrated; n 
3. D, A549 cells were infected with indicated viruses at MOI of 2 for 24 h. Supernatants were analyzed for IFN- expression using IFN- ELISA
(Fujirebio), n  5. E, VeroSF cells were infected with indicated viruses at an MOI of 0.01. Supernatants were collected at indicated time points
and titrated; n  3. C–E: Data represent means 	 S.E. *, p  0.05; **, p  0.01 (Mann-Whitney U test).
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such as metabolic process, biological regulation, biological
adhesion, response to stimulus and apoptotic process (Fig.
4C, supplemental Table S4). Additionally, we generated a
hierarchical cluster analysis as well as corresponding profile
plots (Fig. 5). This scrutiny demonstrated that the vast majority
of the significantly regulated cellular proteins were downregu-
lated upon infection with both viruses (e.g. Cluster c), but with
variations in the extent of regulation (Fig. 5). Cluster d, for
instance, shows proteins with strong downregulation upon
Pan infection, whereas Mal infection decreased protein levels
only moderately (Fig. 5B).
The focus of our study was the identification of protein
signatures discriminating between permissive and nonper-
missive IAV infections. Therefore, we directly compared pro-
tein expression levels in Pan and Mal infected cells at each
single time point post infection and discovered 16 proteins
with at least 2-fold difference (p  0.05) (Fig. 6A, Table I).
These proteins are described to be functionally involved in
biological processes including apoptosis, immune system
process, developmental process, cellular and metabolic proc-
ess (supplemental Fig. S2). Differences in protein expression
levels detected by the MS measurement were evaluated and
confirmed for CrkL, Rsl1D1 (both more abundant in Mal in-
fected cells compared with Pan infected cells (Fig. 6C)) and
VrpBP (decreased expression levels in Mal infected cells
compared with Pan infected cells (Fig. 6C)) for the Pan and
Mal viruses (Fig. 6B–6C), as well as for additional human and
avian strains by immunoblot analysis (Fig. 6B–6D). Infection
with human A/Udorn/307/1972 (Udorn) virus, which also rep-
licates efficiently in A549 cells (44), did not affect protein
expression levels of VprBP and CrkL, but strongly decreased
abundance of Rsl1D1 at 24 h p.i. similar to Pan virus (Fig. 6B,
6D). In contrast, the influenza A/Turkey/Italy/472/1999 (Turk/
It) virus, another representative of low-pathogenic avian IAV
(45) led to decreased abundance of VprBP and increased
CrkL protein levels at 24 h p.i., whereas Rsl1D1 expression
was not affected (Fig. 6B–6D). Taken together, our approach
identified significant changes in the host cell proteome in
response to IAV infection. Most of the 135 proteins were
similarly regulated by both virus strains, but also 16 candi-
dates with distinct changes in permissive versus nonpermis-
sive infection were discovered.
FIG. 2. Schematic representation of “spike-in SILAC” approach. R10K8-labeled A549 cells were mock infected generating the “SILAC
standard.” R0K0 cells were infected with either Pan or Mal virus (MOI 2) for the indicated time points. Same amounts of proteins were mixed
and prepared for measurement by a Q Exactive™ Orbitrap (Thermo Scientific™) equipped with a Nano-LC. The ratio of peak intensities from
the heavy and light peptides display the abundance of the corresponding proteins. MS data were acquired using Xcalibur software and
searched using the Andromeda algorithm in Maxquant 1.5.1.2 against the Homo Sapiens (ncbi) database (89,601 entries). Spiking of light cell
populations with “SILAC standard” enables indirect comparison of light samples; n  2.
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Functional Validation of Significant Protein Signatures by
siRNA-mediated Knockdown—To examine the functional im-
portance of the 16 differentially regulated proteins in IAV
infection, we conducted a limited RNAi-mediated screen by
transfection of three different siRNAs per gene separately in
A549 cells for 48 h. Knockdown of target genes did not affect
overall cell viability (supplemental Fig. S3). After siRNA-medi-
ated knockdown, cells were infected with Pan or Mal virus
and viral titers were determined at 39 h or 48 h p.i., respec-
tively. Genes were classified as affecting virus replication, if
the median of the three different siRNAs as well as at least two
out of three values fell outside the cutoff of 1.5 (Fig. 7). The
described MS measurements had detected Trim47, CrkL and
Grb2 to be more abundant in Mal infected cells at 24 h p.i.,
whereas VprBP expression was decreased in Mal infected
cells compared with Pan (Fig. 6, Table I). The RNAi-mediated
screen revealed that knockdown of Trim47 resulted in de-
creased viral titers of both Pan and Mal virus compared with
negative control, while siRNA-mediated knockdown of CrkL,
Grb2 and VprBP only affected Pan virus replication (Fig. 7).
Based on these findings we suggest that well-balanced ex-
pression levels of CrkL, Grb2 and Trim47 are important for
their correct function during permissive IAV infection. More-
over, we hypothesized that VprBP enhances viral replication
during permissive IAV infection.
VprBP Supports IAV Replication—VprBP is known to bind
and stabilize HIV Vpr/Vpx proteins, inducing cell cycle arrest
in G2 and to direct antiviral host factors such as SAM domain
and HD domain-containing protein 1 (SAMHD1) to protea-
somal degradation (26, 46–50). Furthermore, VprBP can in-
crease replication and protein expression of hepatitis C virus
(HCV) (51). We first performed a viral mini-genome luciferase
assay to analyze if VprBP knockdown has an influence on IAV
gene expression (36). Transfection of Pan vRNP genes PB1,
PB2, PA and NP together with four siRNAs directed against
VprBP mRNA strongly reduced VprBP levels and decreased
viral gene expression significantly to about 62% compared
with negative control siRNA (Fig. 8A). Although cell viability
was not affected by VprBP knockdown (supplemental Fig.
S3), cellular gene expression as measured by Renilla lucifer-
FIG. 3. MS data evaluation revealed quantification of about 3,500 proteins per sample with good correlation between replicates and
time points. A, MS data were acquired using Xcalibur software and searched using the Andromeda algorithm in Maxquant 1.5.1.2 against the
Homo Sapiens (ncbi) database (2014–4; 89,601 protein sequences). Evaluation in Perseus 1.5.0.31 identified about 4000 protein groups per
sample of which 3500 were used for protein quantification. B, Scatter plot analysis of biological replicates at 24 h p.i. Displayed are log2(L/H)
values of Pan (left panel) and Mal (right panel) infected cells and the corresponding Pearson correlation; dots represent protein groups. C,
Principle component analysis using Perseus 1.5.0.31 and 944 significant proteins (p  0.05) having valid values in each sample to determine
structure and variance of MS data. D, Hierarchical cluster analysis by means of IDAS 2.1 (34) using 85 proteins having significant log2(fold
changes) 1 or 1 and valid values in each sample. C–D: Each symbol represents one sample: filled diamond - Pan infected cells, replicate
1; diamond - Pan infected cells, replicate 2; star - Mal infected cells, replicate 1; cross - Mal infected cells, replicate 2; light blue - 0 h p.i.; green
- 4 h p.i.; dark blue - 8 h p.i.; black - 16 h p.i.; pink - 24 h p.i.
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ase activity expressed from a constitutive promoter was im-
paired to nearly the same extent (
70%), suggesting a rather
general role of VprBP as positive regulator for cellular and viral
gene expression (Fig. 8A). This conclusion was supported by
the findings that VprBP overexpression significantly elevated
cellular gene expression (Fig. 8B) and increased viral titers for
both the Pan and Mal viruses (Fig. 8C), accompanied by
enhanced accumulation of viral proteins compared with vec-
tor-transfected cells (Fig. 8C). These findings suggest that
VprBP positively regulates cellular as well as viral gene ex-
pression, thereby supporting IAV replication.
VprBP has been described to facilitate proteasomal degra-
dation of SAMHD1, a known restriction factor for several
human pathogens including hepatitis B virus, herpes simplex
virus, vaccinia virus and retroviruses (52–58). To investigate
the hypothesis that SAMHD1 is regulated in influenza virus
infection we compared its expression in human cells infected
with the Pan or Mal viruses, respectively, at 4 h and 16 h p.i.
in a microscopy approach. Interestingly, this analysis showed
strong reduction of SAMHD1 signals in Pan, but not Mal
infected cells at the late time point (Fig. 8D, supplemental Fig.
S4). Less than 10% of the Pan infected cells were SAMHD1
positive, whereas approx. 60% of the Mal infected cells
showed an SAMHD1 signal above the threshold (Fig. 8D).
Based on this observation we hypothesize that SAMHD1 is
subject to VprBP-dependent downregulation during permis-
sive influenza virus infection.
In summary, we identified protein signatures of permissive
and nonpermissive IAV infection in human lung epithelial cells.
Moreover, our data suggest that VprBP is beneficial for viral
gene expression and supports viral propagation in permissive
IAV infection.
DISCUSSION
Cellular factors that determine the course of avian influenza
virus infection in human cells are poorly defined. Previous
FIG. 4. Statistical evaluation of proteins with significant log2(fold changes) >1 or <1 upon Mal or Pan IAV infection. A, B, Volcano
plot analyses were used to display the changes in protein abundance at early and late time points post infection with Mal (A) and Pan (B) virus,
respectively, in comparison to the 0 h time point: differences between L/H ratio of two samples were plotted against -log(p value); blue:
log2(fold change) 1 or 1, p value0.05; red: log2(fold change) 1 or 1, p value0.05; t test, n  2. C, Classification of proteins with
significant log2(fold change) 1 or 1 upon infection with Pan or Mal virus according to their gene ontology terms “biological process”
(GOBP) using PANTHER (Protein analysis through evolutionary relationships) Classification System Version 10.0.
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quantitative proteome studies of IAV infections focused
mainly on responses in epithelial cells or macrophages to
viruses with different pathogenicity in humans, such as rep-
resentatives of the H1N1 and zoonotic H5N1 or H7N9 sub-
types, respectively (14–20). In contrast, our study aimed to
gain a systematic understanding of the differences in the
proteomes during the courses of permissive and nonpermis-
sive IAV infections and to identify differentially regulated key
factors, as they may be part of the poorly defined species
barrier that prevents regular transmission of avian strains to
humans (59). Our experimental setup investigated the re-
sponses to permissive versus nonpermissive IAV infection
using two H3N2 subtype viruses throughout the course of
infection up to 24 h p.i. Several polymorphisms in the viral
genomes have been associated with host range restrictions of
IAV (10). For instance, a lysine present at position 627 within
the polymerase basic protein 2 (PB2) in most human isolates
confers high-level polymerase activity in human cells com-
pared with the glutamic acid found at this position in the Mal
virus and many other avian IAV isolates (60, 61). The HA
protein of the Mal strain also has the characteristic Gln226/
Gly228 amino acid constellation that confers preferential
binding to 2,3-linked sialic acid receptor determinants,
whereas human strains such as Pan preferentially recognize
2,6-linked sialic acids (62). However, similar efficiencies of
virus uptake (Fig. 1A) and cumulative protein production dem-
onstrated that other determinants play an important role in
restricting Mal virus replication in human cells (Fig. 1B). We
initially eliminated the possibility that the avian Mal virus was
restricted by a strong innate IFN response in human cells as
Mal infected cells secreted only minimal IFN- levels (Fig. 1D)
and Mal virus was similarly attenuated on Vero cells that lack
functional type I IFN genes (63) (Fig. 1E).
We used a spike-in SILAC approach that enabled the com-
parison of different states of infection as well as the proteome
responses to different viruses. For each infection state, we
quantified about 3500 proteins with a strong Pearson corre-
lation of 0.7 to 0.8 between the two replicates (Fig. 2A–2B,
supplemental Fig. S1). Exceptions were the eight and 16-hour
time points of Pan infected cells. Possibly because of high
dynamics of this infection period (Fig. 1C) and a consequent
nonsynchronous infection, cell populations had only a weak
correlation coefficient of 0.3 (supplemental Fig. S1). However,
despite the low Pearson correlation, we identified similar
numbers of significantly changed proteins at these time points
compared with Mal virus infected cells (Supplemental Table
S4). To enable the identification of the most interesting pro-
teins regulated during IAV infection, we applied stringent fil-
ters to the entire data set. Only proteins with a minimum fold
change of two and a p value  0.05 were considered for
further analyses. Interestingly, the 20 generated samples clus-
tered according to the infection period rather than the used
viruses (Fig. 3C–3D), indicating that many changes in cellular
processes occur during both, permissive and nonpermis-
sive IAV infection. In general, we detected more profound
changes in the proteome response at later time points of
infection (Fig. 3C–3D, 4A–4B). Although Pan virus infection
resulted in 1, 20, 33, and 72 proteins with significantly
changed abundance, Mal virus infection led to altered ex-
pression levels of 2, 14, 45, and 58 cellular factors at 4 h,
FIG. 5.Cluster analysis of protein expression pattern during the course of IAV infection. A, Hierarchical cluster analysis based on protein
expression pattern over time generated by means of Perseus software version 1.5.0.31. Used were the Z-scores of 135 identified proteins with
significant log2(fold changes)1 or1 (p value 0.05) and a Euclidean distance threshold of 1.9. B, Profile plots a-f illustrate the expression
patterns of distinct clusters in A.
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8 h, 16 h, and 24 h p.i., respectively (supplemental Table S4).
Those proteins were not only involved in similar biological
processes, e.g. biological regulation, biological adhesion, re-
sponse to stimulus and apoptotic process (Fig. 4C), but also
similarly regulated independent of the virus strain, as revealed
by hierarchical cluster analysis of protein expression levels
(Fig. 5). These observations indicate that the distinct out-
comes of IAV infections in human cells might be determined
by only a few differentially regulated proteins.
To identify protein signatures characteristic for permissive
IAV infection in human cells, we compared protein expression
levels in Pan and Mal infected cells at each single time point
post infection. The 16 proteins identified by at least 2-fold
differential expression (p  0.05) were described to be func-
tionally involved in biological processes such as apoptosis,
immune system process, developmental process, cellular and
metabolic process (Fig. 6A, Fig. S2, Table I). By immunoblot
analysis, differences in protein expression levels were con-
firmed for CrkL, Rsl1D1 and VrpBP (Fig. 6B-C). Furthermore,
we demonstrated that the effect on protein abundance was
not only restricted to Pan and Mal viruses, but matched also
for the permissive seasonal Udorn strain and the low-patho-
genic avian influenza Turk/It virus (Fig. 6B, 6D). Thus, we
confirmed distinct general effects on CrkL, Rsl1D1 and VprBP
protein levels during permissive and nonpermissive infec-
tions, respectively.
To further narrow down which of the 16 differentially regu-
lated factors influence replication efficiency in human cells,
we performed a limited siRNA screen involving targeted
siRNA-mediated knockdown in A549 cells. Thereby, it was
FIG. 6. Identification of protein signatures during permissive versus nonpermissive IAV infection. A, Volcano plot analyses display the
changes in protein abundance due to permissive (Pan) versus nonpermissive (Mal) IAV infection at the indicated time points: differences
between L/H ratio of two samples were plotted against -log(p value); blue: log2(fold change) 1 or 1, p value0.05; red: log2(fold change)
1 or 1, p value0.05; t test, n  2. B, A549 cells were infected with indicated viruses at an MOI of 2 (VprBP) or 3 (CrkL, Rsl1D1),
respectively. At 4 h and 24 h p.i. cell lysates were prepared in 1% SDS buffer. Protein expression levels were analyzed by SDS-PAGE and
immunoblot. Data from one representative experiment of at least three are shown. C, Band intensities of VprBP, Rsl1D1 and CrkL proteins at
the 24 h time point post Mal virus or Turk/It virus infection were quantified, normalized to actin levels and displayed in relation to the protein
expression levels at 24 h Pan virus infection; n 3. D, Band intensities of VprBP, Rsl1D1 and CrkL proteins at 24 h p.i. with the indicated viruses
were quantified, normalized to actin levels and displayed in relation to the protein expression levels at 4 h p.i.; n  3.
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found that knockdown of VprBP, Trim47, CrkL and Grb2
reduced virus replication of Pan, whereas low Mal virus prop-
agation was even further diminished only by Trim47 knock-
down (Fig. 7). Trim47 protein levels were downregulated upon
Pan virus infection, but not affected by Mal virus infection
(Table I). Trim47 has a similar structure as Trim25 known to be
involved in Rig-I activation upon IAV infection (64). Similar to
Trim25, Trim47 can activate the IFN- promoter, as well as
nuclear factor B (NFB)- and IFN-dependent gene expres-
sion (65). However, its role in influenza virus replication has
TABLE I
Differentially regulated proteins in Pan vs. Mal infected A549 cells. Listed are proteins with significant differences upon infection with Pan and
Mal virus at indicated time points calculated by volcano plot analysis (log2(fold change) 1 or  1, p value 0.05; t-test, n  2). Values
represent log2(L/H ratio) of the samples, (	) indicates p value 0.05
4 h p.i. 8 h p.i. 16 h p.i. 24 h p.i.
Gene names Pan Mal sign. Pan Mal sign. Pan Mal sign. Pan Mal sign.
ASPSCR1 1.054 1.517 0.725 0.810 0.118 0.979 0.041 1.135 	
CHTOP 0.035 0.054 0.035 0.025 1.311 0.310 1.266 0.169 	
CRKL 0.513 0.794 0.280 1.069 0.741 1.602 0.350 1.582 	
CYP1B1 0.207 0.574 0.400 0.380 0.223 0.442 0.527 1.769 	
GRB2 0.221 0.381 0.214 0.437 0.794 0.674 0.678 0.729 	
HERC2 0.151 0.870 	 0.623 0.345 0.742 0.608 0.620 0.850
KIAA0101 0.522 0.064 0.821 0.526 2.082 NaN 2.614 1.366 	
MUC5AC 1.313 1.524 1.138 1.066 1.756 0.411 1.509 0.481 	
NRCAM 0.688 0.506 1.047 2.062 	 2.624 3.085 3.031 2.502
POLDIP3 0.095 0.102 0.138 0.106 1.437 0.083 	 2.934 0.139 	
RSL1D1 0.042 0.029 0.155 0.055 0.428 0.261 0.989 0.095 	
TMBIM6 0.201 0.214 0.118 0.165 0.845 0.324 1.732 0.012 	
TRAF2 0.120 0.680 1.191 0.658 	 0.794 NaN 0.101 NaN
TRIM47 0.628 0.704 0.276 0.545 1.385 0.001 1.805 0.248 	
USP36 0.506 0.358 0.475 0.308 0.666 0.514 1.787 0.357 	
VPRBP 0.013 0.397 0.003 0.545 0.181 1.284 0.493 2.149 	
FIG. 7. Functional validation of significant protein signatures by siRNA-mediated knockdown. Three siRNAs per gene (Thermo Fisher)
were used to transfect A549 cells for 48 h. Then, cells were infected with Pan or Mal virus (MOI 0.02) for 39 and 48 h, respectively. Supernatants
were titrated by infection of MDCKII cells for 7 h and NP staining. Normalized values were displayed as Z-score in relation to NP (positive
control) and Allstars siRNA (negative control); n  3. Cut-off:  1.5.
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not been investigated, so far. Our results indicate that a well-
balanced regulation of Trim47 expression levels might be
important in infected human cells, as Trim47 is downregulated
during permissive IAV infection (Table I), whereas its knock-
down negatively affects IAV replication (Fig. 7).
Grb2 is a cellular adapter protein that provides a critical link
between cell surface growth factor receptors and the Raf
signaling pathway (66). Inhibition of Raf signaling results in
nuclear retention of influenza virus ribonucleoprotein com-
plexes, impaired function of the viral nuclear-export protein
and concomitant inhibition of virus production (67). Hemag-
glutinin accumulation of seasonal H3N2 viruses at the cell
surface was reported to trigger Raf signaling (68). Therefore,
Grb2 might be a possible link for HA induced stimulation of
Raf signaling in Pan virus infected cells, while Grb2 knock-
down had only minor effects for Mal virus replication (Fig. 7).
Recently, it was reported that Grb2 is incorporated in virions
of human cytomegalovirus (HCMV), acts as proviral factor for
HCMV replication and is upregulated during infection (69). In
case of IAV, Grb2 is slightly downregulated during permissive
infection and faintly upregulated during nonpermissive infec-
tion (Table I). While isoform 1 is a positive regulator for Raf
signaling, isoform 2 acts as a dominant negative protein over
Grb2 and suppresses proliferative signals (70). However, in
our experimental setup it is not possible to discriminate the
different isoforms of Grb2, because isoform 2 only lacks 40
amino acids of isoform 1 (70). Hence, further mechanistical
investigation is needed to define how Grb2 isoforms affect IAV
infection.
The SH3 domain protein CrkL belongs together with CrkI
and CrkII to the family of Crk adaptor proteins, which are
ubiquitously expressed and function as scaffolds for the for-
mation of protein complexes involved in numerous cellular
signaling processes (71, 72). Previously, it was reported that
interactions of the NS1 proteins of avian IAV and of influenza
B virus with Crk adaptor proteins inhibit influenza virus-medi-
ated activation of c-jun N-terminal kinase (JNK), which results
in suppressed virus-induced apoptosis, whereas reduction of
cellular Crk protein levels led to slightly decreased influenza
virus propagation (73, 74). CrkL knockdown was also reported
to significantly suppress cell viability and phosphorylation of
ERK, which is a downstream kinase of the Raf signaling
FIG. 8. VprBP supports IAV replication. A, B, 293T cells were transiently transfected with the pHW expression plasmids coding for PB1,
PA, PB2, NP and pPol-A/NS-Luc encoding a firefly luciferase cDNA of negative polarity flanked by the noncoding regions of the viral A/NS
segment. The effect of VprBP was analyzed by co-transfection of 50 pmol Flexitube siRNA directed against VprBP (Qiagen, Hilden, Germany)
(A) and by co-transfection of the expression construct (500 ng) (B). Luciferase activity of cells transfected with AllStars Control siRNA or empty
plasmid was set to 100%. Cells not expressing PB1 were used as negative control. Data are means 	 S.E. (A: n  3; B, n  6; biological
duplicates). p values were calculated using Wilcoxon signed rank test. C, A549 cells were transfected with 500 ng VprBP expression plasmid
for 24 h. Then, cells were infected with Pan or Mal virus at an MOI of 1. At 48 h p.i. supernatants were collected and cell lysates were prepared
in 1% SDS buffer. Titers were determined using standard plaque assay and protein content of infected cells was analyzed by immunoblot. Cells
transfected with an empty plasmid were set to 100%. p values were determined by Mann Whitney U test. Data are means 	 S.E. (n  4;
biological duplicates). A–C: *, p  0.05; **, p  0.01; ***, p  0.001. D: A549 cells were infected with Pan or Mal virus at an MOI of 0.5. At 4 h
and 16 h p.i. cells were fixed, permeabilized, stained with specific primary antibody against NP, SAMHD1 and with DAPI. White arrows indicate
NP positive cells with low SAMHD1 expression levels, yellow arrows mark infected cells with high levels of SAMHD1. Images were
representative for three independent experiments. Scale bar: 10 m. Infected cells (white NP signal) were classified according to their SAMHD1
expression levels. Cells with SAMHD1 signal below the threshold of 52 (green signal) were classified as SAMHD1 negative, while cells with
SAMHD1 expression levels above the threshold of 52 were ranked as SAMHD1 positive (red signal). Data are means 	 S.E. (n  3).
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pathway (75). Reduced Pan virus replication due to knock-
down of CrkL seems plausible in light of the finding that
inhibition of Raf signaling decreases IAV propagation (76) (Fig.
7). Mal virus infection led to upregulation of CrkL expression
levels (Table I), but the effects of this increased protein
abundance on Raf signaling and avian IAV infection remain
to be determined. Knockdown of both CrkL and Grb2 indi-
cate a role for the Raf signaling cascade on permissive
influenza virus infection (Table I), but these findings have to
be further investigated to clarify the roles of Grb2 and CrkL
upstream of the Raf signaling cascade in IAV infected hu-
man cells.
VprBP has been described to interact with HIV Vpr and to
support HIV as well as HCV replication (26, 46–51). In this
study, we observed that VprBP has a stimulatory effect on
cellular gene expression, and supports IAV protein accumu-
lation and replication (Fig. 8). SiRNA-mediated reduction of
VprBP levels resulted in decreased viral titers of Pan virus (Fig.
7), which is in confirmation of the finding from a previous study
that detected impaired propagation of influenza WSN/33
virus (H1N1) upon VprBP knockdown (21, 24). In line with our
own results, VprBP protein expression was also not changed
in permissive infections with H7N9, H5N1 and seasonal H1N1
subtype influenza viruses (14). In contrast, VprBP levels were
reduced in Mal virus infected cells and thereby compromised
in their ability to promote virus replication (Table I, Fig. 6),
raising the question for its mode of action. Our data support a
model in which the positive effects of VprBP for cellular and
viral gene expression in infected cells are at least partially
exerted via degradation of its binding partner SAMHD1,
which is known to deplete cellular dNTP levels and to de-
grade viral RNA (56, 58, 77). Indeed, we detected decreased
SAMHD1 expression levels during permissive Pan infection
(Fig. 8D), in analogy to HIV and SIV infected cells (78). IAV
with its single stranded RNA genome that is transcribed in
viral mRNA might be susceptible to the RNase activity of
unaltered SAMHD1 expression during nonpermissive infec-
tion, but this hypothesis remains to be investigated in future
analyses.
In conclusion, by the use of SILAC-based quantitative pro-
teomics, our study identified several interesting factors that
characterize or determine the outcome of an IAV infection in
human cells. Further analyses are warranted to elucidate the
precise roles of these cellular proteins for the success of
influenza virus infections in human host cells. Especially, the
exact role of proviral acting VprBP for influenza virus propa-
gation as well as its suitability as anti-influenza drug target
should be unraveled.
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